0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

THERAPEUTIC USE OF LOCALIZED ALLERGY

Paul D. Garvin, M.D.; Gerald M. Frumess, M.D.
JAMA. 1935;104(26):2333-2334. doi:10.1001/jama.1935.92760260001008.
Text Size: A A A
Published online

During the last few years extensive studies have been made on the circulating antibody (atopic reagin) usually present in atopy, as well as the reaction of the sensitized tissue when brought in contact with the atopen.

The discovery by Prausnitz and Küstner1 in 1921 that the normal skin can be passively sensitized by the intradermal injection of serum containing atopic reagin has been utilized for the diagnosis of atopic conditions. Walzer2 in 1926 demonstrated that the passive transfer site often reacts in the characteristic manner when the specific atopen is ingested orally instead of injected into the sensitized area.

The histologic picture of the allergic wheal has recently been studied by Kline and his associates.3 They find that the essential picture is an inflammation of the dermis and subcutaneous tissue, with edema, vascular engorgement and leukocytosis. At first the eosinophilic leukocytes predominate (first hour), but later the polymorphonuclear neutrophilic and

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();